CO-DEVELOPED ACCREDITED SYMPOSIUM
Saturday, June 20, 0630-0800
Carson A
OBJECTIVES
At the end of this session, participants will be able to:
- Identify the gaps in care for patients with DME and create tools to help bridge these gaps
- Describe the individualized approach to diabetes management as outlined in the Canadian Diabetes Association 2013 clinical practice guidelines
- Discuss the most up-to-date clinical trial data for anti-VEGF use in the treatment of DME
- Better leverage the key roles played by family physicians, endocrinologists and ophthalmologists in the management of DME
SCIENTIFIC PLANNING COMMITTEEGeoff Williams, MD FRCSC ABO (Chair) |
FACULTYNeil Bressler, MD |
Schedule
| 0630 | Welcome and introductions · Geoff Williams |
| 0635 | DME – Bridging the gaps · Peter J. Lin |
| 0650 | Diabetes 101 · David Miller |
| 0705 | A Canadian perspective on DME · David Maberley |
| 0720 | Review of Protocol T results · Neil Bressler |
| 0740 | Panel discussion – Ask the ophthalmologists/endocrinologist/family doctor |
Breakfast will be served.
This symposium was co-developed with Bayer and was planned to achieve scientific integrity, objectivity and balance.
Neil Bressler, MD
Peter Lin, MD
David Maberley, MD
David Miller, MD